- Home
- /
- Treatment
- /
- Page 12
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Palm tocotrienol complex | CADASIL | Hovid Berhad;121 Jalan Tunku Abdul Rahman;Ipoh | June 13, 2017 | |
Active calcium sensing receptor antagonist derived from tetrahydropyrazolopyrimidine | Pulmonary Arterial Hypertension | Takeda Development Centre Europe, Ltd.;61 Aldwych;London | June 13, 2017 | |
Nandrolone decanoate | Duchenne muscular dystrophy | Sarcomed AB;25 St�rtloppsv�gen;H�gersten-Liljeholmen | June 13, 2017 | |
Humanized monoclonal antibody against human PD-1 | Neuroendocrine tumors | Novartis Pharmaceuticals Corporation;One Health Plaza, Bldg. 135-566G;East Hanover, New Jersey, 07936 | June 8, 2017 | |
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker | Diffuse Large B-cell Lymphoma | ADC Therapeutics SA;Route de la Corniche, 3B;Epalinges | June 8, 2017 | |
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker | Mantle cell lymphoma | ADC Therapeutics SA;Route de la Corniche, 3B;Epalinges | June 8, 2017 | |
Oleoylethanolamide | Prader-Willi syndrome | NutriForward, LLC;1312 Brown Trail, Suite E;Bedford, Texas, 76022 | June 8, 2017 | |
Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] | Pancreatic Cancer | Intezyne Technologies, Inc.;3720 Spectrum Boulevard, Suite 104;Tampa, Florida, 33612 | June 8, 2017 | |
2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile | Idiopathic pulmonary fibrosis | Galapagos NV;Generaal de Wittelaan, L11 A#;Mechelen | June 8, 2017 | |
20% Lipid emulsion solution | Local anesthetic systemic toxicity | ResQ Pharma;621 Rose Street;Lincoln, Nebraska, 68502 | June 8, 2017 | |
4�-(p-fluorobenzyl)tylosin A | Onchocerciasis | AbbVie Inc.;Regulatory Affairs, 1 Waukegan Road;North Chicago, Illinois, 60044 | June 8, 2017 | |
Recombinant human fibroblast growth factor receptor 3 | Achondroplasia | TherAchon AG;36 Aeschenvorstadt;Basel | June 2, 2017 | |
Autologous Epstein-Barr specific T-cells | Post-transplant lymphoproliferative disorder | Cell Medica, Inc.;7505 Fannin Street, Suite 200;Houston, Texas, 77054 | May 31, 2017 | |
Etelcalcetide | Pediatric hyperparathyroidism | Amgen, Inc.;1 Amgen Center Drive;Thousand Oaks, California, 91320 | May 31, 2017 | |
L-3,4-Dihydroxy-6-[18F]fluorophenylalanine | Aromatic amino acid decarboxylase deficiency | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 | May 31, 2017 | |
Ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the human COL7A1 gene. | Dystrophic epidermolysis bullosa | Abeona Therapeutics;6555 Carnegie Blvd, Suite 401;Cleveland, Ohio, 44103 | May 24, 2017 | |
Irinotecan liposome injection | Small cell lung cancer | Ipsen Bioscience, Inc.;650 East Kendall Street;Cambridge, Massachusetts, 02142 | May 24, 2017 | |
Resiquimod | Cutaneous T-cell lymphoma | Galderma Research and Development, LLC;14501 North Freeway;Fort Worth, Texas, 76177 | May 24, 2017 | |
Chimeric locked nucleic acid deoxynucleoside phosphorothioate-linked oligonucleotide inhibitor directed against microRNA-155-5p | Cutaneous T-cell lymphoma | Miragen Therapeutics Europe Ltd | May 22, 2017 | |
Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15′-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain | Paroxysmal nocturnal hemoglobinuria | Best Regulatory Consulting Ltd | May 22, 2017 | |
Recombinant adeno-associated viral vector serotype 6 encoding the B-domain-deleted human factor VIII | Haemophilia A | Coté Orphan Consulting UK Limited | May 22, 2017 | |
Recombinant adeno-associated virus serotype 9 vector expressing codon-optimized miniaturized version of DMD gene | Duchenne muscular dystrophy | Bamboo Therapeutics, w wholly owned subsidiary of Pfizer;Worldwide Safety & Regulatory, Pfizer Inc.;Groton, Connecticut, 06340 | May 22, 2017 | |
Bictegravir/emtricitabine/tenofovir disoproxil fumarate | Human Immunodeficiency Virus type 1 infection in pediatric patients | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | May 17, 2017 | |
Sirolimus | Tuberous sclerosis | NobelPharma Co., LTD;12-10 Nihonbashi-kobunacho;Chuo-ku | May 17, 2017 | |
Exenatide | Idiopathic intracranial hypertension | Alan Boyd Consultants Limited;Electra House, Crewe Business Park;Crewe | May 16, 2017 |